Herophilus
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1405 Minnesota St, San Francisco, Califo...Website
www.herophilus.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Herophilus
Herophilus is focused on reinventing neuro drug discovery by integrating human brain models, scaled biology, and machine learning to develop novel drugs aimed at curing complex brain diseases. Their innovative approach emphasizes systematic drug discovery with enhanced therapeutic potential. The company targets the pharmaceutical and biotechnology sectors, particularly those involved in neurological research and treatment. By utilizing advanced organoid technology, Herophilus aims to provide insights into brain diseases and improve drug development processes.Explore more
Herophilus Org Chart
JS
Manager, Business Operations
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Herophilus your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Herophilus recently announced quarterly report
Check out if Herophilus is spiking on competitors!
Funding: Get notified immidiatlly once Herophilus has new funding data
Website visits: Recent activity has been detected on your website
Check if Herophilus has recently received funding, and reach out quickly before it becomes old news!
Herophilus, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Herophilus
Click to see if Herophilus had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Herophilus launches new products
Recommended Actions
Reach out to Masked Content who joined Herophilus as Masked Content
Find 3 more new buyers
Compare Similar Companies to Herophilus
Compare insights from companies similar to Herophilus, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Herophilus is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Herophilus is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Herophilus.
Herophilus Tech Stack
A closer look at the technologies used by Herophilus
See more technologies
Most Recent Scoops
Project
A mid-level source in Operations Management has indicated that the organization is in the midst of initiatives related to office management systems. Herophilus is currently evaluating Dropbox Sign, Envoy, Slack and Zoom.
Office Operations
Project
A mid-level source in Operations Management has indicated that the organization is planning to release a request for proposal (RFP) for initiatives related to forecasting within the next three to six months. Herophilus is currently evaluating vendors to support these efforts.
Forecasting
Project
A mid-level source in Operations Management has indicated that the organization is in the midst of initiatives related to maintenance management. Herophilus is currently evaluating vendors to support these efforts.
Facilities Maintenance
Project
A mid-level source in Operations Management has indicated that the organization is in the midst of initiatives related to emergency management. Herophilus is currently evaluating vendors to support these efforts.
Health & Safety
Project
Software, Facilities Management
Herophilus News & Media
The Rett Syndrome Research Trust Funds Herophilus’ Rett Syndrome Lead Candidate Studies
SAN FRANCISCO--(BUSINESS WIRE)-- #drugdiscovery--Herophilus announced today that in vivo studies underway of its lead candidate HRP-12975 are funded in part by the Rett Syndrome Research Trust (RSRT). HRP-12975 is the first small molecule therapy for Rett Syndrome with the potential to reverse the root cause of the disease, MECP2 deficiency. HRP-12975 is the first novel disease-modifying chemical entity discovered with any brain organoid discovery platform and thus represents an industry first aHerophilus Announces Results from Research Collaboration with Cerevel Therapeutics to Evaluate Novel Neuroimmune Modulating Therapeutic Strategies for Schizophrenia
SAN FRANCISCO--(BUSINESS WIRE)-- #CNS--Herophilus announced today the publication of “Neuroimmune Cortical Organoids Overexpressing C4A Exhibit Multiple Schizophrenia Endophenotypes” in bioRxiv, the preprint server for biology. The findings further demonstrate the emerging role the neuroimmune axis may play in the development of schizophrenia and in providing a platform for schizophrenia drug discovery. The paper reports results from an ongoing research collaboration between Herophilus and CerevHerophilus Appoints Industry Veteran Scott Saywell as Chief Business Officer
SAN FRANCISCO--(BUSINESS WIRE)-- #CuresNotCorrelations--Herophilus appoints industry veteran Scott Saywell as Chief Business OfficerHerophilus Publishes General Method for Detecting Relevant Signals in Machine Learning Analysis of Complex Biological Datasets
SAN FRANCISCO--(BUSINESS WIRE)-- #CuresNotCorrelations--Herophilus publishes general method for detecting relevant signals in machine learning analysis of complex biological datasets
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Herophilus
Sign Up For FreeTo access detailed company insights
Herophilus is focused on reinventing neuro drug discovery by integrating human brain models, scaled biology, and machine learning to develop novel drugs aimed at curing complex brain diseases. Their innovative approach emphasizes systematic drug discovery with enhanced therapeutic potential. The company targets the pharmaceutical and biotechnology... Read More
